Skip to content
Recall Observatory FDA recall evidence

Drug product

Gabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen Pharmaceuticals Inc., Hauppauge, NY 11788, NDC: 50228-177-05.

D-0354-2023

February 17, 2023

Class III

Product summary

Firm
Sciegen Pharmaceuticals Inc
Event
Event 91717
Status
Terminated
Classification
Class III
Quantity
4,392 bottles
Official record key
drug-enforcement:D-0354-2023

Official wording

Reason: Presence of Foreign Tablets/Capsules: Pharmacist reported presence of some Gabapentin tablets 800 mg comingled in Gabapentin 600 mg 500 count bottles.

Code information: Lot # G177092, Exp. 11/24

Distribution pattern: Nationwide in the USA and Puerto Rico

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Foreign Tablets